81 related articles for article (PubMed ID: 12151426)
1. Metabolic characteristics of women who developed ovarian hyperstimulation syndrome.
Delvigne A; Kostyla K; De Leener A; Lejeune B; Cantiniaux B; Bergmann P; Rozenberg S
Hum Reprod; 2002 Aug; 17(8):1994-6. PubMed ID: 12151426
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of inherited thrombophilia in patients with severe ovarian hyperstimulation syndrome.
Machac S; Lubusky M; Prochazka M; Streda R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):289-92. PubMed ID: 17426795
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome.
Dulitzky M; Cohen SB; Inbal A; Seidman DS; Soriano D; Lidor A; Mashiach S; Rabinovici J
Fertil Steril; 2002 Mar; 77(3):463-7. PubMed ID: 11872195
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.
Vecchi M; Sacchi E; Saibeni S; Meucci G; Tagliabue L; Duca F; De Franchis R
Dig Dis Sci; 2000 Jul; 45(7):1465-9. PubMed ID: 10961731
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
7. Analysis of three genetic polymorphisms as risk factors for thrombosis.
Giordano P; Micelli M; Coppola B; Trerotoli P; De Lucia D; Iolascon A
Int J Clin Lab Res; 1999; 29(4):174-5. PubMed ID: 10784380
[No Abstract] [Full Text] [Related]
8. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia.
D'Elia AV; Driul L; Giacomello R; Colaone R; Fabbro D; Di Leonardo C; Florio P; Petraglia F; Marchesoni D; Damante G
Gynecol Obstet Invest; 2002; 53(2):84-7. PubMed ID: 11961379
[TBL] [Abstract][Full Text] [Related]
9. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovarian syndrome and thrombophilia.
Tsanadis G; Vartholomatos G; Korkontzelos I; Avgoustatos F; Kakosimos G; Sotiriadis A; Tatsioni A; Eleftheriou A; Lolis D
Hum Reprod; 2002 Feb; 17(2):314-9. PubMed ID: 11821270
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
[TBL] [Abstract][Full Text] [Related]
12. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.
Foka ZJ; Lambropoulos AF; Saravelos H; Karas GB; Karavida A; Agorastos T; Zournatzi V; Makris PE; Bontis J; Kotsis A
Hum Reprod; 2000 Feb; 15(2):458-62. PubMed ID: 10655323
[TBL] [Abstract][Full Text] [Related]
13. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-->A 20210 prothrombin gene and C-->T 677 MTHFR gene mutations.
Hézard N; Cornillet-Lefebvre P; Gillot L; Potron G; Nguyen P
Thromb Haemost; 1998 May; 79(5):1054-5. PubMed ID: 9609246
[No Abstract] [Full Text] [Related]
14. [Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia].
Procházka M; Krcová V; Kudela M; Slavík L
Ceska Gynekol; 2003 May; 68(3):162-6. PubMed ID: 12879654
[TBL] [Abstract][Full Text] [Related]
15. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of thrombophilia in patients with severe ovarian hyperstimulation syndrome].
Machac S; Procházka M; Lubuský M
Ceska Gynekol; 2005 Jul; 70(4):254-7. PubMed ID: 16128122
[TBL] [Abstract][Full Text] [Related]
17. Placental genotyping of the factor V Leiden, prothrombin 20210A and the methylenetetrahydrofolate reductase (MTHFR) C677T alleles in IUGR pregnancies.
Wisotzkey JD; Bayliss P; Rutherford E; Bell T
Thromb Haemost; 1999 May; 81(5):844-5. PubMed ID: 10365762
[No Abstract] [Full Text] [Related]
18. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct.
Akar N; Akar E; Deda G; Sipahi T; Orsal A
J Child Neurol; 1999 Nov; 14(11):749-51. PubMed ID: 10593555
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk factors in acute coronary disease.
Araújo F; Santos A; Araújo V; Henriques I; Monteiro F; Meireles E; Moreira I; David D; Maciel MJ; Cunha-Ribeiro LM
Haemostasis; 1999; 29(4):212-8. PubMed ID: 10702702
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
